RBC Capital analyst Gregory Renza maintained a Buy rating on ADC Therapeutics (ADCT – Research Report) on January 7 and set a price target of ...
Acknowledging that there is skepticism surrounding its business model and ability to sustain profitability targets, RBC ...
RBC Capital Markets has upgraded the Utilities sector to Overweight, naming it the top defensive sector, while downgrading ...
In a report released on January 7, Luca Issi from RBC Capital maintained a Hold rating on Moderna (MRNA – Research Report), with a price target ...
Fintel reports that on January 9, 2025, RBC Capital upgraded their outlook for Bank of Montreal (NYSE:BMO) from Sector ...
Find insight on BBVA, Australia’s banks and more in the latest Market Talks covering Financial Services.
The research team at RBC Capital Markets published their top 30 global stock ideas for 2025, ...
Exxon Mobil’s shares fell after the company warned its fourth-quarter earnings will take a hit from lower crude prices and narrowing refining margins during the final three months of 2024.
Mihelic hiked his price target on Toronto-listed BMO shares from $133 to $161, while upgrading his rating to “Outperform” ...
Scotiabank analyst Mario Saric thinks the worst may be over for domestic office REITs, ...
RBC Capital analyst Ashish Sabadra maintained a Buy rating on Nasdaq (NDAQ – Research Report) yesterday and set a price target of $95.00. The ...